Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024
Novo Nordisk today announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions ...
Tag: semaglutide
Anti-obesity medications slash heart disease risk in obese patients, study finds
Obesity is a major cause of illness and death, mainly due to cardiovascular disease (CVD), which claims about 18 million ...
Weight-Loss Drug, Approved for Adults, Shows Promise in Kids
Nov. 10, 2022 -- The prospect of being involved in a research program that might help her lose weight intrigued ...